首页> 外文期刊>Therapeutic Drug Monitoring >Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients
【24h】

Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients

机译:危重儿科患者庆大霉素每日一次剂量指导的剂量推导

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To determine dose and eligibility criteria for once-daily dosing (ODD) of gentamicin in critically ill pediatric patients. METHODS: Retrospective chart review of patients admitted to the Pediatric Intensive Care Unit or Cardiac Critical Care Unit at The Hospital for Sick Children (SickKids) who received traditionally dosed intravenous (IV) gentamicin (January 2008 to June 2010). Statistically significant patient characteristics associated with gentamicin pharmacokinetic (PK) parameters were determined by multiple linear regression. Binary partitioning was used to set critical values for these characteristics to derive dose for ODD of gentamicin. Feasibility of implementing ODD of gentamicin in critically ill children was assessed using individualized PK parameters to simulate area under the concentration-time curves and drug-free intervals while targeting a maximum concentration (Cmax) of 16-20 mg/L. Eligibility criteria were determined by patient characteristics that had a statistically significant impact on gentamicin PK. RESULTS: Volume of distribution (Vd) and elimination rate constant (ke) were calculated for 140 patients. Weight and admission unit were significantly associated with weight-normalized Vd (Vd/kg), whereas age and serum creatinine (SCr) were significantly associated with ke. Weight <5 kg and SCr 20% over age-specific upper normal limit before gentamicin initiation were associated with prolonged gentamicin elimination. Gentamicin 6 mg/kg IV every 24 hours, the dose at which the highest percentage of patients achieved Cmax, area under the curve, and drug-free interval within target ranges simultaneously, was selected as the proposed ODD regimen. CONCLUSIONS: A regimen of gentamicin 6 mg/kg IV every 24 hours for Pediatric Intensive Care Unit/Cardiac Critical Care Unit patients at SickKids weighing 5 kg with SCr <20% above age-specific upper normal limit before initiation of gentamicin is proposed.
机译:目的:确定重症儿科患者庆大霉素的每日一次剂量(ODD)的剂量和资格标准。方法:回顾性图表回顾了接受传统剂量静脉注射庆大霉素静脉注射(IV)庆大霉素的病童医院(SickKids)儿童重症监护病房或心脏重症监护病房的患者。通过多次线性回归确定与庆大霉素药代动力学(PK)参数相关的具有统计学意义的患者特征。使用二元分配为这些特征设定临界值,以得出庆大霉素ODD的剂量。使用个体化PK参数评估浓度-时间曲线和无药间隔下的面积,同时针对最大浓度(Cmax)为16-20 mg / L的情况,评估了危重儿童中实施庆大霉素ODD的可行性。资格标准由对庆大霉素PK有统计学显着影响的患者特征决定。结果:计算了140例患者的分布体积(Vd)和消除率常数(ke)。体重和入院单位与体重标准化Vd(Vd / kg)显着相关,而年龄和血清肌酐(SCr)与ke显着相关。庆大霉素开始使用前体重<5 kg,SCr超过年龄特定的正常上限,与庆大霉素的消除时间延长有关。庆大霉素每24小时静脉输注6 mg / kg,即最大百分比的患者同时达到Cmax,曲线下面积和目标范围内的无药物间隔的剂量被选为建议的ODD方案。结论:对于重症监护病房/心脏重症监护病房的SickKids重5 kg,SCr <20%高于特定年龄正常上限的患者,建议每24小时静脉注射庆大霉素6 mg / kg的方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号